Kaisa Health Group Holdings Limited (00876.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 17Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 18

Key dataSep 18, 2026

OpenHKD 1.85

From 52W high−82.52%

Volume17000.00

Market capHKD 9.25B

P/E (TTM)—

P/S (TTM)26.1x

Div yield—

Key dataSep 18, 2026

Open

HKD 1.85

From 52W high

−82.52%

Volume

17000.00

Market cap

HKD 9.25B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−271.3x

P/E (TTM)

—

RSI (14)

40.0

MomentumView details →

1D Return

−4.43%

YTD Return

−47.57%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−271.3x

EV/Sales

28.4x

P/S (TTM)

26.1x

P/B (TTM)

−28.7x

ProfitabilityView details →

Gross Margin

37.64%

Net Margin

−27.60%

EBITDA Margin

−10.49%

ROE (TTM)

30.27%

ROA (TTM)

−5.68%

Asset Turnover

0.32x

GrowthView details →

Revenue YoY

+112.79%

EPS YoY

−19.43%

FCF YoY

—

Revenue CAGR 3Y

−10.11%

EPS CAGR 3Y

+0.00%

EBITDA YoY

−96.96%

MomentumView details →

1D Return

−4.43%

YTD Return

−47.57%

1Y Return

−26.60%

RSI (14)

40.0

vs 50D SMA

−5.14%

vs 200D SMA

−61.20%

Capital & dividendView details →

Debt/Equity

−2.01x

Current Ratio

0.46x

Quick Ratio

0.32x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

520.54M

Net Income (TTM)

−128.94M

Op. CF (TTM)

—

Latest newsMore news →

Kaisa Health Group issued a profit warning, expecting its loss attributable to owners for the six months ended June 2026 to widen to no more than HK$65 million, compared with a restated loss of about HK$7.7 million in the same period last year.32d ago

Kaisa Health's subsidiary Qinghai Pharmaceutical obtained a drug registration certificate for Hydromorphone Hydrochloride Injection, becoming one of only three enterprises nationwide holding a valid production registration certificate for this product.55d ago

Similar companies

Masimo CorporationMASI 圣湘生物688289.SH Repligen CorporationRGEN 海泰新光688677.SH Avantor, Inc.AVTR The Cooper Companies, Inc.COO Find similar companies →

Latest newsMore news →

Kaisa Health Group issued a profit warning, expecting its loss attributable to owners for the six months ended June 2026 to widen to no more than HK$65 million, compared with a restated loss of about HK$7.7 million in the same period last year.32d ago Kaisa Health's subsidiary Qinghai Pharmaceutical obtained a drug registration certificate for Hydromorphone Hydrochloride Injection, becoming one of only three enterprises nationwide holding a valid production registration certificate for this product.55d ago